Hadassah

Hadassah Breakthrough Identifies Carriers of Lynch Syndrome Mutation That Causes Colon and Gynecological Cancers

Friday, Dec 19 2014

While many people know about the BRCA gene mutations that can lead to the development of breast cancer--even more so since renowned actress Angelina Jolie publicized the importance of being tested-- fewer people know about Lynch Syndrome. Yet, testing for this mutation can prevent colon, endometrial, and ovarian cancer and enable early detection of pancreatic and urinary tract cancer, a Hadassah Medical Center research team reveals.

“I'm so passionate about this because I know this testing can save lives,” says Dr. Yael Goldberg, a Hadassah Medical Center oncologist and specialist in oncogenetics who led the research team. “Colon cancer can be prevented or detected early in around 90 percent of carriers of the mutation who do the correct follow-up procedures.”

Dr. Goldberg emphasizes: “If you have colon cancer or endometrial cancer in your family or if your colonoscopy turns up five or more polyps, you should be tested for Lynch Syndrome.  It can literally save your life.” She further notes that our knowledge of typical founder mutations in specified ethnic groups, such as Ashkenazi Jews and Jews from Iran, the former Soviet Republic of Georgia, and Afghanistan, makes testing for the mutation simpler and quicker.

While the prevalence of the Lynch mutation is not as high as the BRCA one in either the general population or the Jewish population, it is significant: estimated as 1:370. In the United States, however, fewer than five percent of those who are at high risk actually get tested. In Israel, mainly due to lobbying by the collaborative research team from Hadassah, Ichilov Hospital/Tel Aviv Sourasky Medical Center, and Beilinson Hospital/Rabin Medical Center, the Israeli health care system will be covering this test as of January 2015.

The overall lifetime risk of developing the cancers associated with Lynch Syndrome has reached 80 percent. Furthermore, when both parents carry the gene mutation, there is a l:4 risk for having a child who carries mutations in both copies of the gene. This can result in a very morbid condition called C-MMRD, Dr. Goldberg reports, where the child is at high risk for a horrendous cluster of deadly cancers.  As with Tay Sachs disease, she brings out, “awareness and screening for Lynch Syndrome could help avoid this condition.”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Jun 19 2018

American Journal of Ophthalmology Article Celebrates the Centennial of Hadassah Ophthalmology

The centennial anniversary of the Hadassah Medical Organization's Department of Ophthalmology is celebrated in the May issue of the American Journal of Ophthalmology, with an article by the immediate past director, Prof. Jacob Pe'er, and the current director, Prof. Itay Chowers.

READ MORE ›

Tuesday, Jun 12 2018

Hadassah Ophthalmology Department Research Highlighted by JAMA

Thanking the Hadassah Medical Organization’s researchers for their ”excellent submission” to JAMA Ophthalmology regarding a multi-center international study of the variable effectiveness of treatment for neovascular age-related macular degeneration (nAMD), the editors explained that their article was one of just a few from 12 JAMA on-line journals to be highlighted in The JAMA Network Reader this weekend.

READ MORE ›
alt_text

Monday, Jun 11 2018

Ruth Radiano: Passionate New Director of Nursing at Hadassah Hospital Mount Scopus

Translating her passion and professionalism into action, Ruth Radiano, the new Director of Nursing at Hadassah Hospital Mount Scopus, brings a background of 26 years of nursing at Hadassah.

READ MORE ›
alt_text

Thursday, Jun 7 2018

Former NYC Mayor Giuliani Calls Hadassah Hospital a Blessing

Former New York City Mayor Rudy Giuliani and his partner Dr. Maria Ryan, CEO of Cottage Hospital in Woodsville, New Hampshire visited Hadassah Medical Organization in Jerusalem today to get an update on Hadassah’s management of terror events.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More